3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase NA
1
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Lymphoma
12
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma, Non-Hodgkin
10
Lymphoma, Mantle-Cell
10
Lymphoma, Large-Cell, Immunoblastic
10
Lymphoma, Follicular
10
Burkitt Lymphoma
10
Leukemia, Myeloid, Acute
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myeloid, Chronic-Phase
8
Leukemia
8
Congenital Abnormalities
8
Myelodysplastic Syndromes
7
Multiple Myeloma
7
Leukemia, Myeloid, Accelerated Phase
7
Myeloproliferative Disorders
6
Hodgkin Disease
6
Blast Crisis
6
Recurrence
5
Primary Myelofibrosis
5
Lymphoma, T-Cell, Cutaneous
5
Leukemia, Hairy Cell
5
Dendritic Cell Sarcoma, Interdigitating
5
Sezary Syndrome
4
Pdgfra-Associated Chronic Eosinophilic Leukemia
4
Neoplasms, Plasma Cell
4
Mycosis Fungoides
4
Leukemia, Neutrophilic, Chronic
4
Interventions
fludarabine
2
Cyclophosphamide
2
zanubrutinib
1
pegfilgrastim
1
obinutuzumab
1
fludarabine phosphate
1
Specimen Handling
1
Resistance Training
1
Radiotherapy
1
Neuropsychological Tests
1
Modafinil
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Injections
1
Filgrastim
1
Contrast Media
1
Blood Specimen Collection
1
Azacitidine
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma, B-Cell
×
Filgrastim
×
Clear all
NCT01541072
2016-11-01
PALM2
Centre Leon Berard
Phase NA
Terminated
34 enrolled